IndiaFilingsIndiaFilings
India FlagRegister India Company
UAE FlagRegister UAE Company
USA FlagRegister USA Company

SHASHWAT CANCER CARE LLP

LLPIN : ACI-1598|ROC: RoC-AhmedabadActive
Last Updated On : 29-08-2025
LLPINACI-1598
LLP NameSHASHWAT CANCER CARE LLP
Number of Partners2
Number of Designated Partners2
ROC CodeRoC-Ahmedabad
Date of Incorporation03-07-2024
Registered AddressSR NO 27, PLOT NO 36, 2nd - 3rd FLOOR CIGIS HOSPITAL, NEAR BALAJI HALL 150 FEET RINGROAD Mavdi Rajkot Rajkot Gujarat India 360004
Email IDdr.alpeshkikani@gmail.com
Total Obligation of Contribution1,00,000
Main division of business activity to be carried out in India46
Description of main divisionWHOLESALETRADE,EXCEPTOFMOTORVEHICLESANDMOTORCYCLES
Date of last financial year end for Annual Return filed31-03-2025
LLP StatusActive

Directors / Signatory Details

SHASHWAT CANCER CARE LLP is a Limited Liability Partnership (LLP) governed by the LLP Act, 2008. Registered under the Registrar of Companies RoC-Ahmedabad, it operates as a non-government entity. According to the Ministry of Corporate Affairs (MCA), this LLP was incorporated on 03-07-2024 and last updated on 29-08-2025. Its LLP Identification Number (LLPIN) is , and the registration number is . Currently, its eFiling status is listed as “Active” as per MCA records.
From a financial standpoint, SHASHWAT CANCER CARE LLP has a total contribution of INR 1,00,000. Details of the latest financial filings, such as the Statement of Accounts and Solvency or Annual Returns, are unavailable, indicating limited publicly disclosed financial data.
The registered office address is SR NO 27, PLOT NO 36, 2nd - 3rd FLOOR CIGIS HOSPITAL, NEAR BALAJI HALL 150 FEET RINGROAD Mavdi Rajkot Rajkot Gujarat India 360004. Correspondence or inquiries may be sent to the official email address, dr.alpeshkikani@gmail.com.
For those interested in further details, below are some frequently asked questions:
Disclaimer

IndiaFilings is not affiliated with any companies listed on this website and does not represent them. Please contact the respective company directly for their inquiries.